Back on July 24, BioWorld took a look at how, “Boosted by COVID-19 success, Taiwan life sciences sector building government, investor support.” After no COVID-19 cases for 100 days, Taiwan looks like a success and, “has drawn attention to its medical achievements.”...
Taiwan
Category
Adimmune Starts COVID-19 Vaccine Trial in Taiwan
Adimmune Corp., the Taiwanese drug maker, reported August 27th that it has started the first phase of human trials for its experimental COVID-19 vaccine. In addition, Phase 2 is likely to follow in November if everything goes well. In announcing the news, Adimmune...
Taiwan Centers for Disease Control Provisionally Approves Dexamethasone for COVID-19
Based on the RECOVERY trial results out of Oxford in the UK, the U.S. NIH sought to place dexamethasone on the clinical guidelines and now Taiwan has provisionally approved the use of dexamethasone, the relatively economical and widely-used steroid. The Authority...
Taiwan’s Chang Gung University Teams with Australian Researchers to Study Potential of Ivermectin Targeting COVID-19
Australia’s Monash University, along with the University of Melbourne and Taiwan’s Chang Gung University, signed a collaboration and nondisclosure agreement centering on the development of new drugs for potential use against viruses, including SARS-CoV-2—the virus...
Lessons from Taiwan’s Response to COVID-19
Taiwan, with about 23 million residents and about 2.7 million visitors from China in 2019, was at high risk for COVID-19. Yet they have only had 267 cases and two deaths. This relative success in our global pandemic warrants a closer look. While we have already...
Taiwan Central Epidemic Command Center Gears up for Remdesivir-based COVID-19 Clinical Trials
Taiwan’s Central Epidemic Command Center announced the commencement of clinical trials for the use of the antiviral drug remdesivir to treat the novel coronavirus (COVID-19). Moreover, the U.S. Food and Drug Administration (FDA) has approved the participation of...
Taipei Medical University (TMU) to Open New Taipei Cancer Center & Add to Robust Clinical Trials Site Infrastructure
Taipei Medical University (TMU), funding the Taipei Cancer Center, is expected to complete construction before the end of 2020 to be in business for patients shortly thereafter. This new state-of-the-art cancer center in Taiwan will introduce proton therapy, a type of...
Stiff Competition for Taiwan’s Clinical Trials
Taiwan and other regional players are finding it difficult to compete on the same scale as China when it comes to hosting clinical trials. Over the years, Taiwan has developed a strong reputation in the field of healthcare. It is now looking to leverage its advantages...
Raypal First to Open Cellular Therapy Center in Southern Taiwan
Established in 2016, Raypal Biomedical specializes in research into immunocytes and immunotherapy, as well as the use of stem cells in cancer treatments. They have signed (on Oct 22nd) a memorandum of understanding with Kaohsiung Medical University Chung-Ho Memorial...
Taiwan Provider Shares Expertise with Peers in Thailand
Changhua Christian Hospital seeks to share the medical expertise, personnel and technological advantages of Taiwan’s health care system with Thailand. The Ministry of Health and Welfare of Taiwan announced a “one country, one hospital” policy in a recent press...
Taiwan Researchers Connect Hidradenitis Suppurativa & Cardiovascular & Metabolic Risk
A prominent group of clinical investigators from Taiwan has produced a nationwide, population-based cohort study evidencing the association of Hidradenitis Suppurativa (HS) and metabolic syndrome and coronary artery disease. A nationwide-level study in Asia, however,...
Taiwan Researchers Identify c-MYC as Possible Biomarker for Oral Squamous Cell Carcinoma Patients
A Taiwan-led research team produces a study evidencing the possibility that c-MYC is a potential biomarker that can be used as a therapeutic targeting for treating oral squamous cell carcinoma (OSCC) patients with T stage (III/IV) are reported in Dovepress. What is...
National Taiwan University to Lead Large Lung Cancer Study at $320K for Nu.Q™ Evaluation
The prestigious National Taiwan University (NTU) will lead a large-scale lung cancer study. Led by Professor Chen Jin-Shing in the Department of Surgery, the study will include 1,200 patients receiving low-dose computed tomography scans, including 1,000 with lung...
Shionogi & Akili to Commercialize Digital Therapeutics in Asian Markets
Japan-based Shionogi & Co., Ltd. (Shionogi) has formed a strategic alliance with digital therapy venture Akili to develop and commercialize digital therapeutics in Asia. The two report in a joint press release that Akili will create first-of-its-kind...